Oculogica’s eye-tracking concussion detector adopted by Minneapolis Clinic of Neurology

Minneapolis Clinic of Neurology, one of the largest neurology clinics in the nation, has recently made the decision to offer Oculogica Inc.’s EyeBox to patients who may have a concussion.

Read More →

CEO Dr. Rosina Samadani joins Christopher Reed in a Webinar to Discuss the Headstrong Concussion Insurance Program

Please join us on August 10th at 12pm CT for a 30 minute webinar to learn about the HeadStrong Concussion Insurance program for high school students, a $0 deductible and no co-pay plan for students in AZ, CA (self-insured schools), MT, MI, MN, WY, WI, and IA, and the EyeBOX, the first and only FDA cleared objective concussion diagnostic device.

Read More →

Oculogica CEO, Dr. Rosina Samadani, and Founder, Dr. Uzma Samadani, Discuss the EyeBOX on the Talk Polymath Podcast

Watch Oculogica CEO, Dr. Rosina Samadani’s, and founder, Dr. Uzma Samadani’s discussion with the Talk Polymath podcast about the EyeBOX and how eye movement can be used to diagnose and treat concussions.

Read More →

CEOX: CEO Interview Series – Rosina Samadani, CEO of Oculogica

Oculogica CEO, Dr. Rosina Samadani, speaks with CEOX for their CEO Interview Series.

Read More →

Oculogica’s New Patent Opens Potential for a CTE Test for Live Subjects

Oculogica receives ground-breaking patent to assess CTE via its eye-tracking technology

Read More →

Oculogica Adds to IP Portfolio with Patent for Assessment of Impairment Due to Cannabis

Oculogica’s patent enables expansion of its eye-tracking based technology to fulfill an unmet need in cannabis impairment detection

Read More →

Oculogica Receives Department of Defense Grant to Develop Wearable Concussion Diagnostic with Pre-eminent Partners

Keller Army Hospital at West Point, Children’s Hospital of Philadelphia, University of Wisconsin-Green Bay and AdHawk Microsystems will work with Oculogica to develop the wearable diagnostic

Read More →

Australia’s TGA Grants Approval to First Objective Concussion Diagnostic

Oculogica, a medical device company and leader in concussion diagnosis and categorization, announced today the Therapeutic Goods Administration (TGA) of Australia granted approval to its EyeBOX technology. The test is for both pediatrics and adults. The technology is also patent protected in Australia.

Read More →

Oculogica Adds to IP Portfolio with Patent for Glaucoma

Oculogica, the leader in non-invasive assessment of concussion, announces today the granting of U.S. Patent No. 10,863,902 by the U.S. Patent and Trademark Office. This patent protects Oculogica’s method and system for assessing glaucoma in a patient using a noninvasive eye tracking system.

Read More →

Oculogica’s Drs. Rosina and Uzma Samadani Named in Fast Company’s Annual List of the Most Creative People in Business

Oculogica Founder, Dr. Uzma Samadani and CEO, Dr. Rosina Samadani, join the 11th annual list of women and men from such companies as Netflix, Google, and Patagonia, as well as institutions such as Johns Hopkins University and the ACLU of Massachusetts.

Read More →

Recent News

September 2021
Scroll to Top